Indole alkoloids from Nauclea officinalis with weak antimalarial activity
Jingyong Sun1, Hongxiang Lou, Shengjun Dai
1School of Pharmacy, Shandong University, Jinan 250012, People's Republic of China.
Phytochemistry
|March 11, 2008
Summary
Five new indole alkaloids, naucleofficines A-E, were isolated from Nauclea officinalis. These compounds, along with two known ones, showed weak to moderate activity against Plasmodium falciparum in vitro.
Area of Science:
- Phytochemistry
- Natural Products Chemistry
- Medicinal Chemistry
Background:
- Nauclea officinalis is a plant species traditionally used in ethnomedicine.
- Indole alkaloids are a diverse class of natural products with a wide range of biological activities.
- Monoterpene indole alkaloids with glycosidic linkages are relatively rare.
Purpose of the Study:
- To isolate and characterize new indole alkaloids from the stems of Nauclea officinalis.
- To evaluate the in vitro antimalarial activity of the isolated compounds against Plasmodium falciparum.
Main Methods:
- Phytochemical investigation involving extraction and isolation techniques.
- Structure elucidation using comprehensive spectroscopic methods, including 1D and 2D NMR.
- In vitro antimalarial activity screening using Plasmodium falciparum.
Main Results:
- Five new indole alkaloids, named naucleofficines A-E, were successfully isolated and identified.
- Two known indole alkaloids, naucleidinal and angustoline, were also isolated.
- Compounds 2 and 3 represent rare monoterpene indole alkaloids featuring a glucopyranosyloxy group at the C-12 position.
- The seven isolated compounds exhibited weak to moderate inhibitory activity against Plasmodium falciparum.
Conclusions:
- The study successfully identified novel indole alkaloids from Nauclea officinalis.
- The isolated compounds, particularly naucleofficines A-E, demonstrate potential as antimalarial agents.
- Further research into the structure-activity relationship and mechanism of action is warranted.
Related Concept Videos
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...

